Lyra Therapeutics, Inc. (LYRA) Operating cash flow 2019–2025
Lyra Therapeutics, Inc. (LYRA) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$28.9MFY2025 · since FY2019: -$13.8M → -$28.9M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$28.9M | +58.8% |
| FY2024 | -$70.0M | -10.6% |
| FY2023 | -$63.3M | -45.9% |
| FY2022 | -$43.4M | -68.0% |
| FY2021 | -$25.8M | -22.1% |
| FY2020 | -$21.1M | -53.7% |
| FY2019 | -$13.8M | — |
Source: SEC XBRL filings · For reference only · Not investment advice